EcoDrugPlus

Integrin, Alpha 2b

Ensembl ID : ENSIPUG00000023401
Gene Symbol: ITGA2B
3 Cross references
190 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSIPUG00000018509
Gene Symbol: ITGA5
3 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSIPUG00000002925
Gene Symbol: ITGAV
3 Cross references
238 Possible Orthologues:

Integrin, Beta 1

Ensembl ID : ENSIPUG00000012386
Gene Symbol: ITGB1
2 Cross references
221 Possible Orthologues:

Integrin, Beta 1a

Ensembl ID : ENSIPUG00000000200
Gene Symbol: ITGB1A
3 Cross references
215 Possible Orthologues:

Integrin, Beta 5

Ensembl ID : ENSIPUG00000021957
Gene Symbol: ITGB5
3 Cross references
210 Possible Orthologues:

Integrin, Beta 7

Ensembl ID : ENSIPUG00000020007
Gene Symbol: ITGB7
2 Cross references
150 Possible Orthologues:

Integrin, Beta 8

Ensembl ID : ENSIPUG00000004139
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSIPUG00000014731
Gene Symbol: IRAK4
2 Cross references
202 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSIPUG00000023732
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSIPUG00000000405
Gene Symbol: LOC100304677
3 Cross references
207 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSIPUG00000016583
Gene Symbol: KEAP1B
3 Cross references
189 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).